Cellectis SA
SWB:ZVAA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cellectis SA
SWB:ZVAA
|
FR |
|
G
|
Goldwind Science & Technology Co Ltd
XMUN:CXGH
|
CN |
|
L
|
LTC Properties Inc
SWB:LTP
|
US |
|
D
|
Dohome PCL
SET:DOHOME
|
TH |
|
H
|
Homology Medicines Inc
SWB:35H
|
US |
|
T
|
TX Group AG
SIX:TXGN
|
CH |
|
F
|
FirstService Corp
F:1GIA
|
CA |
|
Mauna Kea Technologies SA
PAR:ALMKT
|
FR |
|
Infroneer Holdings Inc
TSE:5076
|
JP |
|
Xinjiang Goldwind Science & Technology Co Ltd
F:CXGH
|
CN |
Wall St Price Targets
ZVAA Price Targets Summary
Cellectis SA
According to Wall Street analysts, the average 1-year price target for
ZVAA is 8.83 EUR with a low forecast of 8.75 EUR and a high forecast of 9.09 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZVAA's stock price target?
Price Target
8.83
EUR
According to Wall Street analysts, the average 1-year price target for
ZVAA is 8.83 EUR with a low forecast of 8.75 EUR and a high forecast of 9.09 EUR.
What is the Revenue forecast for Cellectis SA?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 7 years is 21%.
What is the Gross Profit forecast for Cellectis SA?
Projected CAGR
162%
The compound annual growth rate for Gross Profit over the next 1 year is 162%.